Raynaud's phenomenon.
Belch
J J
JJ
Ninewells Hospital and Medical School, Dundee, Scotland, UK.
D000917:Antibody Formation; D001808:Blood Vessels / Q000502:physiology; D004730:Endothelium, Vascular / Q000276:immunology / Q000503:physiopathology; D005228:Fatty Acids, Essential / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D007650:Ketanserin / Q000627:therapeutic use; D008833:Microcirculation; D009424:Nervous System Physiological Phenomena; D009543:Nifedipine / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D009626:Terminology as Topic; D014661:Vasoconstriction
D005228:Fatty Acids, Essential; D007650:Ketanserin; D009543:Nifedipine